Pharmagen, Inc. announced that Russell Skibsted has been appointed as its Executive Vice President and Chief Financial Officer. Most recently, Mr. Skibsted was Sr. Vice President, Chief Financial Officer and Secretary of Aeolus Pharmaceuticals.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
2015 | Pharmagen, Inc. cancelled the transaction announced on November 30, 2012 | CI |
2014 | Pharmagen, Inc. Announces Management Changes | CI |
- Stock Market
- Equities
- PHRX Stock
- News Pharmagen, Inc.
- Pharmagen, Inc. Appoints Russell Skibsted as Executive Vice President and Chief Financial Officer